Last updated: April 24, 2026

Application No. 19/387,928

Untitled Application

Unknown

Filed

1600

Examiner

WILSON, JERICA KATLYNN

Art Unit

1621

Tech Center

Lenz Therapeutics Operations, Inc.

Assignee

Lenz Therapeutics Operations Inc.

OA Round

1 (Non-Final)

This examiner grants 61% of cases after interview

— +39.5% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 94 resolved cases, 2023–2026

Examiner Intelligence

WILSON, JERICA KATLYNN View full profile →

Grants 61% of resolved cases

Career Allow Rate

57 granted / 94 resolved

+0.6% vs TC avg

Strong +40% interview lift

Without

With

+39.5%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

39 currently pending

Career history

133

Total Applications

across all art units

Statute-Specific Performance

§101

1.8%

-38.2% vs TC avg

§103

34.4%

-5.6% vs TC avg

§102

18.6%

-21.4% vs TC avg

§112

27.3%

-12.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 94 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 20, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/430,721

Patent 12582722

BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY

2y 5m to grant Granted Mar 24, 2026

17/782,632

Patent 12533357

TREATMENT FOR ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME

2y 5m to grant Granted Jan 27, 2026

16/486,223

Patent 12527788

Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor...

2y 5m to grant Granted Jan 20, 2026

17/430,240

Patent 12527759

COMPOSITIONS COMPRISING AMINO ACIDS FOR USE AND TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES

2y 5m to grant Granted Jan 20, 2026

17/640,294

Patent 12503484

Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure.

2y 5m to grant Granted Dec 23, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

61%

Grant Probability

99%

With Interview (+39.5%)

3y 3m

Median Time to Grant

Low

PTA Risk

Based on 94 resolved cases by this examiner. Grant probability derived from career allow rate.